NewAmsterdam Pharma Ownership | Who Owns NewAmsterdam Pharma?


OverviewForecastRevenueFinancialsChart

NewAmsterdam Pharma Ownership Summary


NewAmsterdam Pharma is owned by 22.74% institutional investors, 0.25% insiders, and 77.01% retail investors. Fcpm iii services b.v. is the largest institutional shareholder, holding 11.18% of NAMS shares. American Funds SMALLCAP World A is the top mutual fund, with 2.88% of its assets in NewAmsterdam Pharma shares.

NAMS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockNewAmsterdam Pharma22.74%0.25%77.01%
SectorHealthcare Stocks 57.47%9.40%33.13%
IndustryBiotech Stocks 69.06%8.93%22.01%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fcpm iii services b.v.10.60M11.18%$272.35M
Jennison associates4.00M4.22%$102.76M
Medicxi ventures management (jersey)2.87M3.03%$73.75M
Polar capital1.75M1.85%$44.98M
Timessquare capital management895.57K0.95%$23.02M
Blackrock funding, inc. /de441.52K0.47%$11.35M
Handelsbanken fonder ab187.40K0.20%$4.82M
Abrdn179.06K0.19%$4.60M
Healthinvest partners ab138.98K0.15%$3.56M
Moody aldrich partners79.14K0.08%$2.03M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Fcpm iii services b.v.10.60M45.98%$272.35M
Medicxi ventures management (jersey)2.87M13.94%$73.75M
Healthinvest partners ab138.98K1.69%$3.56M
Moody aldrich partners79.14K0.38%$2.03M
Timessquare capital management895.57K0.34%$23.02M
Polar capital1.75M0.25%$44.98M
Lisanti capital growth38.72K0.24%$994.98K
Gsa capital partners llp54.23K0.10%$1.39M
Jennison associates4.00M0.06%$102.76M
China universal asset management19.59K0.05%$503.44K

Top Buyers

HolderShares% AssetsChange
Jennison associates4.00M0.06%2.98M
Timessquare capital management895.57K0.34%640.33K
Blackrock funding, inc. /de441.52K0.00%374.85K
Polar capital1.75M0.25%245.00K
Handelsbanken fonder ab187.40K0.02%187.40K

Top Sellers

HolderShares% AssetsChange
Bvf inc/il---1.52M
Fcpm iii services b.v.10.60M45.98%-1.23M
Ensign peak advisors---245.57K
Moody aldrich partners79.14K0.38%-137.35K
Baker bros. advisors lp---96.71K

New Positions

HolderShares% AssetsChangeValue
Handelsbanken fonder ab187.40K0.02%187.40K$4.82M
Tudor investment corp et al52.21K0.01%52.21K$1.34M
China universal asset management19.59K0.05%19.59K$503.44K
Keybank national association/oh9.98K0.00%9.98K$256.56K
Hb wealth management8.73K0.00%8.73K$224.31K

Sold Out

HolderChange
Global retirement partners-91.00
Stone house investment management-325.00
Quarry lp-6.50K
Venture visionary partners-10.00K
Rosalind advisors-10.12K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202433-67.96%21,547,862-71.71%220.35%19-71.64%8-52.94%
Sep 30, 202410311.96%76,172,3465.78%801.39%6724.07%17-
Jun 30, 20249221.05%72,012,804-0.19%760.99%54-6.90%1754.55%
Mar 31, 202476123.53%72,152,34116.57%871.56%58286.67%11120.00%
Dec 31, 202334-5.56%61,897,68023.35%752.03%15-16.67%5-16.67%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
American Funds SMALLCAP World A3.08M2.88%3.08M
Polar Capital Biotech S Inc1.75M1.63%500.00K
Vanguard Health Care Inv1.28M1.20%1.28M
PGIM Jennison Health Sciences Z1.28M1.19%-
Jennison Health Sciences Equity1.28M1.19%789.52K
Pictet-Biotech P USD899.04K0.82%-1.31K
Jennison SMid Cap Core Equity715.47K0.67%715.47K
PGIM Jennison Small Company A715.47K0.67%-
MEDICAL BioHealth EUR Acc632.26K0.59%-
Candriam Eqs L Biotech C USD Cap608.67K0.57%42.03K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 04, 2025Topper James N-Buy$84.20K
Mar 04, 2025Kooij Louise Frederika Chief Accounting OfficerSell$3.06M
Feb 19, 2025Kling Douglas F Chief Operating OfficerSell$177.26K
Feb 18, 2025Kling Douglas F Chief Operating OfficerSell$1.77M
Jan 30, 2025Kling Douglas F Chief Operating OfficerSell$190.14K

Insider Transactions Trends


DateBuySell
2025 Q1114
2024 Q4126
2024 Q32-
2024 Q21-
2024 Q121

NAMS Ownership FAQ


Who Owns NewAmsterdam Pharma?

NewAmsterdam Pharma shareholders are primarily institutional investors at 22.74%, followed by 0.25% insiders and 77.01% retail investors. The average institutional ownership in NewAmsterdam Pharma's industry, Biotech Stocks , is 69.06%, which NewAmsterdam Pharma falls below.

Who owns the most shares of NewAmsterdam Pharma?

NewAmsterdam Pharma’s largest shareholders are Fcpm iii services b.v. (10.6M shares, 11.18%), Jennison associates (4M shares, 4.22%), and Medicxi ventures management (jersey) (2.87M shares, 3.03%). Together, they hold 18.43% of NewAmsterdam Pharma’s total shares outstanding.

Does Blackrock own NewAmsterdam Pharma?

BlackRock is not among the top 10 institutional shareholders of NewAmsterdam Pharma.

Who is NewAmsterdam Pharma’s biggest shareholder by percentage of total assets invested?

Fcpm iii services b.v is NewAmsterdam Pharma’s biggest shareholder by percentage of total assets invested, with 45.98% of its assets in 10.6M NewAmsterdam Pharma shares, valued at 272.35M$.

Who is the top mutual fund holder of NewAmsterdam Pharma shares?

American Funds SMALLCAP World A is the top mutual fund holder of NewAmsterdam Pharma shares, with 2.88% of its total shares outstanding invested in 3.08M NewAmsterdam Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools